Consortium Tracking Tumor Mutations to Guide Lung Cancer Treatment, Clinical Trial Inclusion

By testing 1,000 individuals with lung cancer for driver mutations in 10 genes, members of the Lung Cancer Mutation Consortium are finding mutations to help physicians offer more targeted treatment and clinical trial options for those with the disease.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.